Scientists reported that RGX-202, an oral small-molecule SLC6A8 transporter inhibitor, robustly inhibited creatine import in vitro and in vivo, reduced intracellular phosphocreatine and ATP levels, and induced tumor apoptosis.
[Science Advances]
7992332
{7992332:CCCCCCCC}
apa
50
1
167577
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/